InsidersTradesSigma
Track the 디알텍 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 디알텍 has recorded 41 insider filings. Market capitalisation: €67bn. The latest transaction was filed on 23 June 2026 (Other). Among the most active insiders: 윤정기. All data is openly available.
41
Insider Decl.
n/a
Thresholds
€5,735
16 ops.
Buy Volume
n/a
8 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,562 of 29,064 companies
16.1
score / 100
Value7
Quality25
FCF yld-34%
Earn yld-30%
EV/EBITDA·
ROE-16%
Gross mgn36%
Net mgn-21%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 June 2026
Declarations41 total
5,591,277 sharesKRXDART:20240528000432
25 of 41 declarations
关于 디알텍
디알텍 是一家在医疗保健和制药领域运营的公司，在 XKRX 市场上市。该公司专注于开发医疗领域的创新解决方案。